Search results
Showing 3646 to 3660 of 8239 results
In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Referral points to virtual wards are similar to traditional models of care. Our guidance and advice can help you decide where to provide care and what to consider.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
In virtual wards, patients remain at home to receive hospital-level care. Our guidance can help you determine if patients are suitable for admission to the virtual wards system.
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Our resource planner tool to help you plan for and implement NICE guidance.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
The NHS 2022/23 priorities and operational planning guidance, sets a lead role for Integrated Care Systems in tackling health inequalities.
Health inequalities are differences in health across the population, and between different groups in society, that are systematic, unfair and avoidable.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (HTG521)
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.